TRB-2 inhibitors represent a class of chemical compounds designed to target and modulate the activity of tribbles homolog 2 (TRB-2), a protein that plays a crucial role in various cellular processes. TRB-2, a member of the tribbles pseudokinase family, is recognized for its involvement in intracellular signaling pathways that regulate cellular differentiation, proliferation, and apoptosis. These inhibitors are meticulously crafted to specifically interact with TRB-2, hindering its enzymatic or signaling functions, and thereby influencing downstream cellular responses.The design and development of TRB-2 inhibitors involve a sophisticated understanding of the structural and functional attributes of the TRB-2 protein.
Researchers employ various computational and experimental techniques to identify small molecules or compounds that can selectively bind to TRB-2, disrupting its normal physiological functions. Structural biology techniques, such as X-ray crystallography or nuclear magnetic resonance spectroscopy, contribute to elucidating the three-dimensional architecture of TRB-2 and guide the rational design of inhibitors. Furthermore, medicinal chemistry approaches optimize the pharmacokinetic and pharmacodynamic properties of these inhibitors to enhance their efficacy and specificity. The exploration of TRB-2 inhibitors opens avenues for advancing our understanding of the intricate molecular mechanisms governing cellular processes and holds promise for potential applications in various fields of research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including MAPK, which can reduce TRIB2 levels by inhibiting downstream signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which plays a critical role in the MAPK pathway. Its inhibition can indirectly affect TRIB2 functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. As PI3K signaling regulates the stability of TRIB2, its inhibition can lead to reduced TRIB2 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. PI3K signaling influences TRIB2 stability, so its inhibition can indirectly inhibit TRIB2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. JNK is another kinase involved in the MAPK pathway, so its inhibition can also indirectly reduce TRIB2 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibiting p38 MAPK can affect TRIB2 activity due to its role in the MAPK pathway. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of NF-κB activation. As NF-κB is known to regulate TRIB2 expression, its inhibition can lead to decreased TRIB2 activity. | ||||||
IKK 16 | 1186195-62-9 | sc-204009 sc-204009A | 10 mg 50 mg | $223.00 $942.00 | 2 | |
IKK-16 is an inhibitor of IKK, which is involved in the activation of NF-κB. Its inhibition can affect TRIB2 activity through the NF-κB pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, which is part of the PI3K/AKT pathway, it can indirectly affect TRIB2 activity. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Akti-1/2 is a selective inhibitor of Akt1 and Akt2. Akt is involved in the PI3K/AKT pathway, so its inhibition can indirectly inhibit TRIB2. | ||||||